
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Oncology, Markers, Clinical Correlates |
5 Gene Expression as a Prognostic Factor in Node-negative Non-Small Cell Lung Cancer1
Department of Thoracic Surgery and Department V of Oncology, Kitano Hospital, Tazuke Kofukai Medical Research Institute, Kita-ku, Osaka 530-8480 [M. A., T. T., M. M.]; Department of Surgery, The Center for Adult Diseases of Osaka, Osaka 537-0025 [M. H.]; Second Department of Internal Medicine, Ehime University School of Medicine, Ehime 791-0295 [N. K.]; and First Department of Surgery, Kinki University School of Medicine, Osaka 589-8511 [H. I.], Japan
The
integrin family plays a major role in complex biological events such as
differentiation, development, wound healing, and the altered adhesive
and invasive properties of tumor cells. Integrin
5ß1
is a classical fibronectin receptor, and it has been known as a tumor
suppressor gene because tumor cells overexpressing
5ß1
are less tumorigenic than their parent cells. However, this finding
conflicts with some recent data that suggests that the emergence of
5ß1 expression correlates with the tumor progression. We,
therefore, investigated the expression of
5ß1 integrin in 20 lung
cancer cell lines by flow cytometric analysis and in 88 node-negative
non-small cell lung cancers (NSCLCs) by RT-PCR and immunohistochemical
assays to determine the significance of this prognostic factor. In the
20 lung cancer cell lines, 8 (40.0%) cell lines strongly expressed
integrin
5, 3 (15.0%) cell lines had moderate or weak
5
expression, and the remaining 9 (45.0%) cell lines expressed no
integrin
5. In the 88 node-negative NSCLC patients, 44 samples
(50.0%) were evaluated as having integrin
5 overexpression, and the
integrin
5 expression was significantly associated with the status
of differentiation and the age of the patients (P = 0.0379 and
0.0312, respectively). In the node-negative patients, the overall
survival rate for patients with integrin
5 overexpressed tumors was
significantly worse than for those individuals whose tumors had normal
integrin
5 expression (P = 0.016).
This article has been cited by other articles:
![]() |
K. Sawada, A. K. Mitra, A. R. Radjabi, V. Bhaskar, E. O. Kistner, M. Tretiakova, S. Jagadeeswaran, A. Montag, A. Becker, H. A. Kenny, et al. Loss of E-Cadherin Promotes Ovarian Cancer Metastasis via {alpha}5-Integrin, which Is a Therapeutic Target Cancer Res., April 1, 2008; 68(7): 2329 - 2339. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zheng, J. D. Ritzenthaler, J. Roman, and S. Han Nicotine Stimulates Human Lung Cancer Cell Growth by Inducing Fibronectin Expression Am. J. Respir. Cell Mol. Biol., December 1, 2007; 37(6): 681 - 690. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tokuhara, N. Hattori, H. Ishida, T. Hirai, M. Higashiyama, K. Kodama, and M. Miyake Clinical Significance of Aminopeptidase N in Non-Small Cell Lung Cancer. Clin. Cancer Res., July 1, 2006; 12(13): 3971 - 3978. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Spangenberg, E. U. Lausch, T. M. Trost, D. Prawitt, A. May, R. Keppler, S. A. Fees, D. Reutzel, C. Bell, S. Schmitt, et al. ERBB2-Mediated Transcriptional Up-regulation of the {alpha}5{beta}1 Integrin Fibronectin Receptor Promotes Tumor Cell Survival Under Adverse Conditions. Cancer Res., April 1, 2006; 66(7): 3715 - 3725. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Han, H. N. Rivera, and J. Roman Peroxisome Proliferator-Activated Receptor-{gamma} Ligands Inhibit {alpha}5 Integrin Gene Transcription in Non-Small Cell Lung Carcinoma Cells Am. J. Respir. Cell Mol. Biol., April 1, 2005; 32(4): 350 - 359. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yuan, T.-M. Hong, J. J. W. Chen, W. H. Tsai, and M. T. Lin Syndecan-1 up-regulated by ephrinB2/EphB4 plays dual roles in inflammatory angiogenesis Blood, August 15, 2004; 104(4): 1025 - 1033. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Tamoto, M. Tada, K. Murakawa, M. Takada, G. Shindo, K.-i. Teramoto, A. Matsunaga, K. Komuro, M. Kanai, A. Kawakami, et al. Gene-Expression Profile Changes Correlated with Tumor Progression and Lymph Node Metastasis in Esophageal Cancer Clin. Cancer Res., June 1, 2004; 10(11): 3629 - 3638. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G. Stupack, X. S. Puente, S. Boutsaboualoy, C. M. Storgard, and D. A. Cheresh Apoptosis of adherent cells by recruitment of caspase-8 to unligated integrins J. Cell Biol., October 29, 2001; 155(3): 459 - 470. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |